Tyrosine kinase inhibition in acute myeloid leukemia

By Altman Jessica K.   Szilard Amy K.   Platanias Leonidas C.  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1351-1352

Informa Healthcare

Access to resources Recommend Favorite

Specific immune responses against epitopes derived from Aurora kinase A and B in acute myeloid leukemia

By Schneider Vanessa   Egenrieder Stephanie   Götz Marlies   Herbst Cornelia   Greiner Jochen   Hofmann Susanne  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1500-1504

Informa Healthcare

Access to resources Recommend Favorite

Re-evaluation of various molecular targets located on CD34+CD38-Lin- leukemia stem cells and other cell subsets in pediatric acute myeloid leukemia

By            

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 891-897

Spandidos Publications

Access to resources Recommend Favorite

A novel compound against oncogenic Aurora kinase A overcomes imatinib resistance in chronic myeloid leukemia cells

By                  

International Journal of Oncology, Vol. 46, Iss. 6, 2015-01 ,pp. : 2488-2496

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells

By                  

Oncology Reports, Vol. 29, Iss. 5, 2013-01 ,pp. : 1785-1788

Spandidos Publications

Access to resources Recommend Favorite